Ovarian Cancer: Options and Risks1 - Options:Patients are categorized as a patient

Cancer Patient Quality Of LifeThe concept of quality of life has been critically

LYNPARZA is the only PARP inhibitor approved for the 4 types of advanced cancer."The

Okay, so I’ve got a patient with advanced ovarian cancer. What are the options

LYNPARZA is the only PARP inhibitor approved for the following 4 types of advanced

So it's actually been a very exciting time in the last couple of years. For

PARP inhibitors have a significant role to play in the treatment and management

The main purpose is to damage cancer cells. Since cancer cells are faster than

Dexamethasone or hydrocortisone would suppress the local inflammation caused

Some key points to keep in mind while preparing ADO-TRASTUZUMAB EMTANSINE: